Prostate Cancer Medicine Market Size - Global Outlook and Forecast 2022-2028

11 January 2022
Life Sciences
73 Pages
Report code : 24WT-6706394

Prostate Cancer Medicine Market

1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Medicine Overall Market Size
2.1 Global Prostate Cancer Medicine Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Medicine Players in Global Market
3.2 Top Global Prostate Cancer Medicine Companies Ranked by Revenue
3.3 Global Prostate Cancer Medicine Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Medicine Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Medicine Market Size Markets, 2021 & 2028
4.1.2 LHRH Antagonists
4.1.3 LHRH Analogs
4.1.4 Antiandrogens
4.1.5 Pipeline Drugs for Hormonal Therapy
4.2 By Type - Global Prostate Cancer Medicine Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Medicine Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Medicine Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Medicine Market Size, 2021 & 2028
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - Global Prostate Cancer Medicine Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Medicine Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Medicine Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Medicine Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Medicine Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Medicine Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Medicine Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Medicine Revenue, 2017-2028
6.3.2 US Prostate Cancer Medicine Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Medicine Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Medicine Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Medicine Market Size, 2017-2028
6.4.3 France Prostate Cancer Medicine Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Medicine Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Medicine Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Medicine Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Medicine Revenue, 2017-2028
6.5.2 China Prostate Cancer Medicine Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Medicine Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Medicine Market Size, 2017-2028
6.5.6 India Prostate Cancer Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Medicine Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Medicine Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Medicine Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Medicine Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Medicine Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Medicine Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Corporate Summary
7.1.2 AstraZeneca plc Business Overview
7.1.3 AstraZeneca plc Prostate Cancer Medicine Major Product Offerings
7.1.4 AstraZeneca plc Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca plc Key News
7.2 Active Biotech
7.2.1 Active Biotech Corporate Summary
7.2.2 Active Biotech Business Overview
7.2.3 Active Biotech Prostate Cancer Medicine Major Product Offerings
7.2.4 Active Biotech Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.2.5 Active Biotech Key News
7.3 Bristol Myers-Squibb
7.3.1 Bristol Myers-Squibb Corporate Summary
7.3.2 Bristol Myers-Squibb Business Overview
7.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Major Product Offerings
7.3.4 Bristol Myers-Squibb Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.3.5 Bristol Myers-Squibb Key News
7.4 Teva Pharmaceuticals Industries Ltd.
7.4.1 Teva Pharmaceuticals Industries Ltd. Corporate Summary
7.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Major Product Offerings
7.4.4 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.4.5 Teva Pharmaceuticals Industries Ltd. Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Medicine Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Corporate Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Prostate Cancer Medicine Major Product Offerings
7.6.4 Pfizer Inc. Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.6.5 Pfizer Inc. Key News
7.7 Bayer AG
7.7.1 Bayer AG Corporate Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Prostate Cancer Medicine Major Product Offerings
7.7.4 Bayer AG Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.7.5 Bayer AG Key News
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Corporate Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Prostate Cancer Medicine Major Product Offerings
7.8.4 Abbott Laboratories Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.8.5 Abbott Laboratories Key News
7.9 Astellas Pharma Inc.
7.9.1 Astellas Pharma Inc. Corporate Summary
7.9.2 Astellas Pharma Inc. Business Overview
7.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Major Product Offerings
7.9.4 Astellas Pharma Inc. Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.9.5 Astellas Pharma Inc. Key News
7.10 Roche Holding AG
7.10.1 Roche Holding AG Corporate Summary
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Prostate Cancer Medicine Major Product Offerings
7.10.4 Roche Holding AG Prostate Cancer Medicine Revenue in Global Market (2017-2022)
7.10.5 Roche Holding AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

Ask Our Expert

List of Tables
Table 1. Prostate Cancer Medicine Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Medicine Market Drivers in Global Market
Table 3. Prostate Cancer Medicine Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Medicine in Global Market
Table 5. Top Prostate Cancer Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Medicine Product Type
Table 9. List of Global Tier 1 Prostate Cancer Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Prostate Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Prostate Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Prostate Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca plc Corporate Summary
Table 31. AstraZeneca plc Prostate Cancer Medicine Product Offerings
Table 32. AstraZeneca plc Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Active Biotech Corporate Summary
Table 34. Active Biotech Prostate Cancer Medicine Product Offerings
Table 35. Active Biotech Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Bristol Myers-Squibb Corporate Summary
Table 37. Bristol Myers-Squibb Prostate Cancer Medicine Product Offerings
Table 38. Bristol Myers-Squibb Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Teva Pharmaceuticals Industries Ltd. Corporate Summary
Table 40. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product Offerings
Table 41. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Prostate Cancer Medicine Product Offerings
Table 44. Johnson & Johnson Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Inc. Corporate Summary
Table 46. Pfizer Inc. Prostate Cancer Medicine Product Offerings
Table 47. Pfizer Inc. Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 48. Bayer AG Corporate Summary
Table 49. Bayer AG Prostate Cancer Medicine Product Offerings
Table 50. Bayer AG Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 51. Abbott Laboratories Corporate Summary
Table 52. Abbott Laboratories Prostate Cancer Medicine Product Offerings
Table 53. Abbott Laboratories Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Astellas Pharma Inc. Corporate Summary
Table 55. Astellas Pharma Inc. Prostate Cancer Medicine Product Offerings
Table 56. Astellas Pharma Inc. Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Roche Holding AG Corporate Summary
Table 58. Roche Holding AG Prostate Cancer Medicine Product Offerings
Table 59. Roche Holding AG Prostate Cancer Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Prostate Cancer Medicine Segment by Type in 2021
Figure 2. Prostate Cancer Medicine Segment by Application in 2021
Figure 3. Global Prostate Cancer Medicine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca plc Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Active Biotech Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol Myers-Squibb Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Inc. Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer AG Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abbott Laboratories Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astellas Pharma Inc. Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Holding AG Prostate Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

SECURITY ASSURED payment image

Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research

Frequently Asked Questions ?

User License

A license granted to one user.
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
Multi user License
A license granted to multiple users.
Site License
A license granted to a single business site/establishment.
Corporate License, Global License
A license granted to all employees within organisation access to the product.

Delivery Time

Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

WHY CHOOSE US

Proactive We manage our resources 24/7 to identify issues and address them before they become problems
Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach 6 Major regions and 40+ countries level analysis accomplished
Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery